Metabolism-based
Cancer Therapy Symposium 2024

Tuesday, November 26, 2024・ONLINE

In the last decade cancer metabolism has emerged as a cancer hallmark. Although it has been almost a century since Otto Warburg described a difference in cellular metabolism in cancer cells, cancer-specific metabolic alterations have not been fully exploited therapeutically. Increasing numbers of studies showed both the complexity and the promise of targeting metabolism as a therapeutic strategy in cancer. It is time for scientists and clinicians working on this strategy to meet and exchange their experience.

With a translational focus, the symposium brings together oncologists and researchers interested in exploiting the metabolic bias of tumors for therapeutic interventions. It aims to shed light and bring to discussion novel translational approaches that are either currently under clinical testing or show translational potential in preclinical studies.  

Organizing Team

Dr. med. Ekaterina Balaian, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Martin Bornhäuser, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Dr. med. Triantafyllos Chavakis, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Dr. Mohamed Elgendy, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Dr. Leoni Kunz-Schughart, OncoRay - National Center of Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
 

Scientific administration

Dr. med. Ekaterina Balaian, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Prof. Martin Bornhäuser, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Dr. Mohamed Elgendy, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Prof. Dr. Leoni Kunz-Schughart, OncoRay - National Center of Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Prof. Dr. med. Triantafyllos Chavakis, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

 

Organizer

GWT-TUD GmbH
Freiberger Straße 33
01067 Dresden

Conference time

Tuesday, November 26, 2024・ONLINE
12:00 p.m. until 5 p.m.

Broadcast

via Zoom

Continuing Medical Education Credits (CME)

The CME credits have been applied for at the Saxon State Medical Association. We expect approx. 4 continuing medical education credits.

Felix Manthei
Projektmanager

Mobile: +49 163 250 72 07
Phone: +49 351 25 933 210

GWT-TUD GmbH
Freiberger Straße 33
01067 Dresden

Novarts Pharma AG (2.000,- €)

Photo credit: Graphic elements designed by Freepik